Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC

Clinical trial NCT07777822 · RECRUITING

Trial details

NCT number: NCT07777822
Sponsor: Revolution Medicines, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

NSCLC Non-small Cell Lung Cancer Non-Small Cell Lung Cancer NSCLC Non-Squamous Non Small Cell Lung Cancer Lung Cancer (NSCLC)Metastatic NSCLC - Non-Small Cell Lung Cancer Metastatic Non-Squamous Non-Small Cell Lung Cancer

Start date: 2026-08-14
Primary completion: 2029-10-01
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.